These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 11472272)
41. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism. Pfützner A; Forst T Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812 [TBL] [Abstract][Full Text] [Related]
43. Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems. Lin YJ; Mi FL; Lin PY; Miao YB; Huang T; Chen KH; Chen CT; Chang Y; Sung HW Adv Drug Deliv Rev; 2019 Jan; 139():71-82. PubMed ID: 30529306 [TBL] [Abstract][Full Text] [Related]
44. Population pharmacokinetic model of human insulin following different routes of administration. Potocka E; Baughman RA; Derendorf H J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337 [TBL] [Abstract][Full Text] [Related]
45. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies. Sintov AC; Levy HV; Botner S J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120 [TBL] [Abstract][Full Text] [Related]
46. Nasal delivery of insulin using bioadhesive chitosan gels. Varshosaz J; Sadrai H; Heidari A Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591 [TBL] [Abstract][Full Text] [Related]
47. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung. Patton JS Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136 [TBL] [Abstract][Full Text] [Related]
48. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term. Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235 [TBL] [Abstract][Full Text] [Related]
54. Celebrating a Century of Insulin Discovery: A Critical Appraisal of the Emerging Alternative Insulin Delivery Systems. Sibiya N; Mbatha B; Ngubane P; Khathi A Curr Drug Deliv; 2023; 20(6):656-668. PubMed ID: 35642116 [TBL] [Abstract][Full Text] [Related]
55. [Drug delivery system for diabetes]. Yamasaki Y Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368 [TBL] [Abstract][Full Text] [Related]
56. [Inhaled insulin: a model for pulmonary systemic absorption?]. Becquemin MH; Chaumuzeau JP Rev Mal Respir; 2008 Feb; 25(2):209-22. PubMed ID: 18449082 [TBL] [Abstract][Full Text] [Related]
57. Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics. Sakagami M Clin Pharmacokinet; 2004; 43(8):539-52. PubMed ID: 15170368 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of inhaled insulin therapy for diabetes mellitus. Siddiqui NI Mymensingh Med J; 2007 Jul; 16(2):237-45. PubMed ID: 17703168 [TBL] [Abstract][Full Text] [Related]
59. Noninjectable methods of insulin administration. Cernea S; Raz I Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235 [TBL] [Abstract][Full Text] [Related]
60. Effect of insulin concentration on bioavailability during nasal spray administration. Valensi P; Zirinis P; Nicolas P; Perret G; Sandre-Banon D; Attali JR Pathol Biol (Paris); 1996 Apr; 44(4):235-40. PubMed ID: 8763584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]